Literature DB >> 12204971

Helicobacter pylori-specific immune responses of children: implications for future vaccination strategy.

Günter Bode1, Isolde Piechotowski, Dietrich Rothenbacher, Hermann Brenner.   

Abstract

We analyzed the specific anti-Helicobacter pylori immunoglobulin G (IgG) antibody profile for a sample of 824 asymptomatic schoolchildren in southern Germany (mean age, 10.7 +/- 0.65 years) with an H. pylori-specific IgG enzyme-linked immunosorbent assay and Western blot analysis. The prevalence of infection was 19.8% (95% confidence interval, 17.1 to 22.7%). The immunoresponses were characterized predominantly by antibodies against low-molecular-mass antigens of 14 and 29 kDa, with a significant difference between children of German and Turkish nationalities (P = 0.0012 and P < 0.0001, respectively).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12204971      PMCID: PMC120080          DOI: 10.1128/cdli.9.5.1126-1128.2002

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  30 in total

Review 1.  Helicobacter pylori genetic diversity and risk of human disease.

Authors:  M J Blaser; D E Berg
Journal:  J Clin Invest       Date:  2001-04       Impact factor: 14.808

2.  Immunoblotting and serology for diagnosis of Helicobacter pylori infection in children.

Authors:  J Raymond; C Sauvestre; N Kalach; M Bergeret; C Dupont
Journal:  Pediatr Infect Dis J       Date:  2000-02       Impact factor: 2.129

3.  Acquisition of Helicobacter pylori infection in a high-risk population occurs within the first 2 years of life.

Authors:  D Rothenbacher; J Inceoglu; G Bode; H Brenner
Journal:  J Pediatr       Date:  2000-06       Impact factor: 4.406

4.  CagA antibodies in Japanese children with nodular gastritis or peptic ulcer disease.

Authors:  S Kato; T Sugiyama; M Kudo; K Ohnuma; K Ozawa; K Iinuma; M Asaka; M J Blaser
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

5.  The role of serology in the diagnosis of Helicobacter pylori infection in children.

Authors:  J G Sim; E C Kim; J K Seo
Journal:  Clin Pediatr (Phila)       Date:  1995-09       Impact factor: 1.168

6.  Seroprevalence of eight Helicobacter pylori antigens among 182 patients with peptic ulcer, MALT gastric lymphoma or non-ulcer dyspepsia. Higher rate of seroreactivity against CagA and 35-kDa antigens in patients with peptic ulcer originating from Europe and Africa.

Authors:  D Lamarque; T Gilbert; F Roudot-Thoraval; L Deforges; M T Chaumette; J C Delchier
Journal:  Eur J Gastroenterol Hepatol       Date:  1999-07       Impact factor: 2.566

7.  Immunoblot analysis of humoral immune response to Helicobacter pylori in children with and without duodenal ulcer.

Authors:  G A Rocha; A M Oliveira; D M Queiroz; A S Carvalho; A M Nogueira
Journal:  J Clin Microbiol       Date:  2000-05       Impact factor: 5.948

8.  Discrepancy between polymerase chain reaction assay and Western blot analysis in the assessment of CagA status in dyspeptic patients.

Authors:  O A Paoluzi; P Rossi; C Montesano; S Bernardi; E Carnieri; O P Marchione; F Nardi; F Iacopini; R Pica; P Paoluzi
Journal:  Helicobacter       Date:  2001-06       Impact factor: 5.753

9.  Serologic response to lower-molecular-weight proteins of H. pylori is related to clinical outcome of H. pylori infection in Taiwan.

Authors:  S C Shiesh; B S Sheu; H B Yang; H J Tsao; X Z Lin
Journal:  Dig Dis Sci       Date:  2000-04       Impact factor: 3.199

10.  Importance in diagnosis of gastritis of detection by PCR of the cagA gene in Helicobacter pylori strains isolated from children.

Authors:  M O Husson; F Gottrand; A Vachee; L Dhaenens; E M de la Salle; D Turck; M Houcke; H Leclerc
Journal:  J Clin Microbiol       Date:  1995-12       Impact factor: 5.948

View more
  1 in total

1.  Antibody-based detection tests for the diagnosis of Helicobacter pylori infection in children: a meta-analysis.

Authors:  Yelda A Leal; Laura L Flores; Laura B García-Cortés; Roberto Cedillo-Rivera; Javier Torres
Journal:  PLoS One       Date:  2008-11-18       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.